Streetbeat News

Earnings

KAI

Kadant Inc. has projected its 2024 revenue to be between $1.04 billion and $1.065 billion, surpassing the estimated $968.02 million. Additionally, the company expects its adjusted EPS to range from $9.75 to $10.05, which is around the estimated $9.86.

Portfolio Pulse from Benzinga Newsdesk

February 14, 2024 | 10:10 pm

DYN

Dyne Therapeutics, Inc. (NASDAQ:DYN) announced its participation in the 2024 Muscular Dystrophy Association Clinical & Scientific Conference with two presentations on initial clinical data from its ACHIEVE and DELIVER trials in DM1 and DMD patients, respectively. The data, first reported in January 2024, demonstrated proof-of-concept for its DM1 and DMD programs, validating the FORCE platform's targeted delivery to muscle. Additional data from these trials is expected in the second half of 2024. The ACHIEVE trial evaluates DYNE-101 in DM1 patients, while the DELIVER trial assesses DYNE-251 in DMD patients amenable to exon 51 skipping. Both trials have shown promising initial results and safety data.

Portfolio Pulse from Benzinga Newsdesk

February 14, 2024 | 10:09 pm

FORD

Forward Industries reported Q1 earnings with a per-share loss of $(0.04), unchanged from last year, and a 26.67% decrease in sales to $7.15M from $9.75M YoY.

Portfolio Pulse from Happy Mohamed

February 14, 2024 | 10:08 pm

UPWK

Upwork, Inc. (NASDAQ:UPWK) exceeded Q4 earnings and revenue expectations, reporting earnings of 20 cents per share and quarterly sales of $183.9 million, surpassing analyst estimates. The company also reported a 5% year-over-year increase in active clients, reaching 851,000. CEO Hayden Brown highlighted Upwork's growth momentum, profitability, and strategic investments in AI, advertising, subscription products, and partnerships. Upwork provided strong guidance for Q1 and full-year 2024, expecting higher earnings and revenue than analyst estimates. Following the announcement, Upwork shares rose by 4.99% in after-hours trading.

Portfolio Pulse from Erica Kollmann

February 14, 2024 | 10:06 pm

QIPT

Quipt Home Medical (QIPT) reported a Q1 EPS of $(0.01), down from $0.01 YoY, with sales of $65.40M missing the $65.57M estimate, yet marking a 60.29% increase from last year.

Portfolio Pulse from totan@benzinga.com

February 14, 2024 | 10:05 pm

GPMT

Granite Point Mortgage (NYSE:GPMT) reported Q4 2023 adjusted EPS of $0.14, surpassing the $(0.29) estimate, but missed sales estimates with $17.33M against the expected $19.65M. This represents a 17.40% decrease in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

February 14, 2024 | 10:05 pm

KNW

Know Labs reported a Q1 EPS loss of $(0.04), marking a 50% improvement from the $(0.08) per share loss reported in the same period last year.

Portfolio Pulse from Happy Mohamed

February 14, 2024 | 10:04 pm

WFG

West Fraser Timber reported Q4 sales of $1.51 billion, surpassing the estimated $1.47 billion.

Portfolio Pulse from Benzinga Newsdesk

February 14, 2024 | 10:03 pm

TGL

Treasure Global reported a significant decrease in its Q2 2024 revenue, posting $6.7M, down from $20.4M in the same quarter the previous year.

Portfolio Pulse from Benzinga Newsdesk

February 14, 2024 | 10:03 pm